Company Filing History:
Years Active: 2009-2010
Title: Innovations in Cancer Monitoring by Peter J Hamer
Introduction
Peter J Hamer is a notable inventor based in Reading, MA (US), recognized for his contributions to cancer patient monitoring technologies. With a total of 2 patents, Hamer has developed innovative methods that significantly enhance the ability to track the progression of cancer and the effectiveness of treatments.
Latest Patents
Hamer's latest patents focus on assays for cancer patient monitoring. The first patent describes methods for examining and monitoring cancer patients based on levels of analyte components of the plasminogen activator system in body fluid samples. This invention provides a clinically important method for assessing the progression of disease and treatment effectiveness by measuring specific analytes, such as uPA and PAI-1, in patient samples. An increase in these analytes compared to normal control individuals indicates cancer advancement or a lack of treatment effectiveness.
The second patent outlines methods for monitoring cancer patients through the levels of the epidermal growth factor receptor (EGFR) extracellular domain (ECD) analyte. This invention allows for the assessment of disease progression and treatment effectiveness by measuring the ECD levels in patient samples. A decrease in EGFR levels, in conjunction with elevated HER-2/neu levels, serves as an indicator of poor outcomes and short time to progression.
Career Highlights
Peter J Hamer is currently associated with Siemens Healthcare Diagnostics GmbH, where he continues to innovate in the field of cancer diagnostics. His work has had a significant impact on how cancer treatment outcomes are monitored, providing valuable insights for healthcare professionals.
Collaborations
Hamer has collaborated with notable colleagues, including Walter P Carney and Allan Lipton, to advance research and development in cancer monitoring technologies.
Conclusion
Peter J Hamer's contributions to cancer patient monitoring through his innovative patents have the potential to improve treatment outcomes and patient care. His work exemplifies the importance of innovation in the medical field, particularly in the fight against cancer.